SCHEMBL6983919

SCHEMBL6983919

Cc1nc2cc(C=O)ccc2c(=O)[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.56
TNKS2 Q9H2K2 1/20 0.56
KDM4E B2RXH2 3/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
USP2 O75604 1/20 0.55
ALDH1A1 P00352 1/20 0.55
GLA P06280 1/20 0.55
GAA P10253 1/20 0.55
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
IP6K1 Q92551 1/20 0.55
HSD17B10 Q99714 2/20 0.48
LMNA P02545 1/20 0.48
TYMS P04818 7/20 0.46
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TRPV1 Q8NER1 2/20 0.42
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28017671 0.87 IP6K1 (0.71) PARP1TNKS2KDM4ENPC1RAB9A
SCHEMBL18681236 0.84 IP6K1 (0.59) PARP1TNKS2KDM4ENPC1RAB9A
SCHEMBL19773889 0.84 IP6K1 (0.59) PARP1TNKS2KDM4ENPC1RAB9A
SCHEMBL6985209 0.80 KDM4E (0.42) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL17460813 0.80 PARP1 (0.62) PARP1TNKS2KDM4ENPC1RAB9A
SCHEMBL30704851 0.80 PARP1 (0.62) PARP1TNKS2KDM4ENPC1RAB9A
SCHEMBL889055 0.78 CYP2A6 (0.44) KDM4ENPC1RAB9AUSP2ALDH1A1
SCHEMBL31271793 0.78 IP6K1 (0.52) PARP1TNKS2KDM4ENPC1RAB9A
SCHEMBL3226572 0.77 TYMS (0.63) PARP1TNKS2KDM4ENPC1RAB9A
SCHEMBL29440611 0.77 TYMS (0.63) PARP1TNKS2KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324029-A1 THERAPEUTIC AGENTS MERCK SHARP & DOHME CORP. 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324029-A1 THERAPEUTIC AGENTS PSEN2, PSEN1, BACE2 PARP1 1371/4885TNKS2 1469/4885KDM4E 3970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.